Bendamustine Hydrochloride Injection
Product Images NDC 83831-183

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 83831-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Progression-free Survival (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 01)

A Kaplan-Meier survival curve chart depicting progression-free survival (months) comparing Bendamustine Hydrochloride with Chlorambucil. The y-axis shows the survival distribution function, and the x-axis shows time in months. Bendamustine Hydrochloride is represented by a solid line, while Chlorambucil is represented by a dashed line.*

FDA Label Image

Bendamustine Hydrochloride Injection 100 mg_4 mL Ct (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 02)

The image shows the packaging label for Bendamustine Hydrochloride Injection 100 mg/4 mL (25 mg/mL) multiple-dose vial. The label indicates intravenous infusion use only and highlights the requirement to dilute the dose in a 500 mL infusion bag of 0.9% Sodium Chloride Injection or 2.5% Dextrose/0.45% Sodium Chloride Injection before administration. It is labeled by Avyxa Pharma, LLC, with storage instructions for refrigeration between 2°C and 8°C.*

FDA Label Image

Bendamustine Hydrochloride Injection 100 mg_4 mL Vial (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 03)

Label for Bendamustine Hydrochloride Injection 100 mg/4 mL (25 mg/mL) sterile intravenous injection in a 4 mL multiple-dose vial. Manufactured by Avyxa Pharma, LLC, the label includes storage instructions, dilution requirements, and warnings about hazardous drug handling. It directs dilution in a 500 mL infusion bag of specified fluids prior to administration.*

FDA Label Image

Image (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 107 1)

FDA Label Image

Image (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 82 1)

Chemical structure of bendamustine hydrochloride, an active ingredient in BENDAMUSTINE HYDROCHLORIDE injection. The diagram shows atoms and bonds including chlorine atoms, a benzene ring fused to an imidazole ring, and a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.